142 filings
Page 2 of 8
8-K
t5fwztpb
8 Nov 22
Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
4:23pm
8-K
bw6 bi68kto0
8 Sep 22
Mirati Therapeutics Presents Late-Breaking Adagrasib Monotherapy and Combination Results in Advanced Colorectal Cancer
6:08am
8-K
hjibsde6akd6kxf6y3
3 Aug 22
Mirati Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Updates
4:04pm
8-K
txhm9gipc gy
7 Jun 22
Other Events
8:06am
8-K
n7b builnvjz
6 Jun 22
Presentation marks first clinical dataset with a KRASG12C-inhibitor in patients with active, untreated CNS metastases
8:07am
8-K
bhju5 d25gd
26 May 22
Other Events
5:06pm
8-K
vh35m8el
16 May 22
Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
4:42pm
8-K
nd4vla9s6 qdpy3
12 May 22
Departure of Directors or Certain Officers
5:07pm
8-K
0tsk y3a1bajevmav
4 May 22
Mirati Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Updates
4:10pm
8-K
4n97mnri0r00vfu
28 Feb 22
Mirati Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates
4:06pm
8-K
w0eq5vtd82km8 djun1r
15 Feb 22
Other Events
4:16pm
8-K
ntebrb4ua mc3xw
10 Jan 22
Regulation FD Disclosure
10:55am
8-K
kkdgxwav cxvgd8
12 Nov 21
Mirati Therapeutics Announces Proposed Public Offering of Common Stock
6:16am
8-K
8ntj f44qr6
9 Nov 21
Other Events
12:00am
8-K
bhwiig
8 Nov 21
Mirati Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
4:08pm
8-K
umhyvpeenc 40
1 Nov 21
Departure of Directors or Certain Officers
7:32am
8-K
s10d 855f
20 Sep 21
Mirati Therapeutics Appoints David Meek as Chief Executive Officer
8:10am
8-K
jm9f43gqiah6a8lmh5j
5 Aug 21
Mirati Therapeutics Reports Second Quarter 2021 Financial Results
4:37pm
8-K
r8lxlj2ynie2oa l66
5 Aug 21
Mirati Therapeutics Reports Second Quarter 2021 Financial Results
4:34pm
8-K
qfblrs
2 Jul 21
Other Events
4:04pm